内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

肢端肥大症多学科管理共识

2020-09-10 肢端肥大症共识工作组 Rev Endocr Metab Disord . 2020 Sep 10.

肢端肥大症

第13届肢端肥大症共识会议于2019年11月在佛罗里达州劳德尔堡召开，一个多学科专家小组针对肢端肥大症的多学科管理进行讨论并最终达成共识

中文标题：

肢端肥大症多学科管理共识

英文标题：

Multidisciplinary management of acromegaly: A consensus

发布机构：

肢端肥大症共识工作组

发布日期：

2020-09-10

简要介绍：

第13届肢端肥大症共识会议于2019年11月在佛罗里达州劳德尔堡召开，一个多学科专家小组针对肢端肥大症的多学科管理进行讨论并最终达成共识

相关资料下载：
[AttachmentFileName(sort=1, fileName=肢端肥大症多学科管理共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6d3c61c0019e997f, title=肢端肥大症多学科管理共识, enTitle=Multidisciplinary management of acromegaly: A consensus, guiderFrom=Rev Endocr Metab Disord . 2020 Sep 10., authorId=0, author=, summary=第13届肢端肥大症共识会议于2019年11月在佛罗里达州劳德尔堡召开，一个多学科专家小组针对肢端肥大症的多学科管理进行讨论并最终达成共识, cover=https://img.medsci.cn/2020929/1601392636668_2020535.jpg, journalId=0, articlesId=null, associationId=597, associationName=肢端肥大症共识工作组, associationIntro=null, copyright=0, guiderPublishedTime=Thu Sep 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>第13届肢端肥大症共识会议于2019年11月在佛罗里达州劳德尔堡召开，一个多学科专家小组针对肢端肥大症的多学科管理进行讨论并最终达成共识</p> </div> </div> </div>, tagList=[TagDto(tagId=11390, tagName=肢端肥大症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11390, guiderKeyword=肢端肥大症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2107, appHits=122, showAppHits=0, pcHits=418, showPcHits=1985, likes=1, shares=5, comments=5, approvalStatus=1, publishedTime=Wed Sep 30 00:26:26 CST 2020, publishedTimeString=2020-09-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 29 23:17:22 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 01:17:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肢端肥大症多学科管理共识.pdf)])
肢端肥大症多学科管理共识.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=973690, encodeId=b8cc9e3690f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 11:41:23 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898259, encodeId=323f8982595c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d885409355, createdName=一支烟, createdTime=Tue Nov 10 15:51:12 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890078, encodeId=367d8900e8f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/7b71d9474897421d993e0275dd2acf76/3ab05e1b548d454dbb939e16e8f8e694.jpg, createdBy=85fe2106008, createdName=ms7091174821454264, createdTime=Sun Oct 04 14:06:01 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2021-06-15 ms8000000656093431

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=973690, encodeId=b8cc9e3690f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 11:41:23 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898259, encodeId=323f8982595c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d885409355, createdName=一支烟, createdTime=Tue Nov 10 15:51:12 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890078, encodeId=367d8900e8f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/7b71d9474897421d993e0275dd2acf76/3ab05e1b548d454dbb939e16e8f8e694.jpg, createdBy=85fe2106008, createdName=ms7091174821454264, createdTime=Sun Oct 04 14:06:01 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-11-10 一支烟

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=973690, encodeId=b8cc9e3690f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 11:41:23 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898259, encodeId=323f8982595c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d885409355, createdName=一支烟, createdTime=Tue Nov 10 15:51:12 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890078, encodeId=367d8900e8f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/7b71d9474897421d993e0275dd2acf76/3ab05e1b548d454dbb939e16e8f8e694.jpg, createdBy=85fe2106008, createdName=ms7091174821454264, createdTime=Sun Oct 04 14:06:01 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-10-04 ms7091174821454264

    学习了

    0

相关指南

2019 KES立场声明：生长抑素类似物治疗肢端肥大症

韩国内科协会(KAIM,Korean Association of Internal Medicine) · 2019-03-20

2014 TES临床实践指南：肢端肥大症

美国内分泌学会(TES,The Endocrine Society) · 2014-10-30

肢端肥大症专家共识（2013年更新）

肢端肥大症共识工作组(ACG,Aeromegaly Consensus Group) · 2014-02-25

中国肢端肥大症诊治指南（2013版）

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-07-01

2011 AACE肢端肥大症诊疗指南（更新版）

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2011-07-30

拓展阅读

2011 AACE肢端肥大症诊疗指南（更新版）

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2011-07-30

中国肢端肥大症诊治指南（2013版）

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-07-01

肢端肥大症专家共识（2013年更新）

肢端肥大症共识工作组(ACG,Aeromegaly Consensus Group) · 2014-02-25

2014 TES临床实践指南：肢端肥大症

美国内分泌学会(TES,The Endocrine Society) · 2014-10-30

2019 KES立场声明：生长抑素类似物治疗肢端肥大症

韩国内科协会(KAIM,Korean Association of Internal Medicine) · 2019-03-20

2020 PS指南：肢端肥大症的管理（更新版）

垂体协会(PS,The Pituitary Society) · 2020-10-20